Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kenta Matoba"'
Autor:
Agena Suzuki, Akinori Hayashi, Satoshi Oda, Rei Fujishima, Naoya Shimizu, Kenta Matoba, Tomomi Taguchi, Takuya Toki, Takeshi Miyatsuka
Publikováno v:
Endocrine Journal, Vol 71, Iss 8, Pp 767-775 (2024)
The beneficial effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors in people with type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD) have been suggested in several reports based on serological markers,
Externí odkaz:
https://doaj.org/article/00f5eb93060f4668a8fda6c2d44d6ba1
Autor:
Akinori Hayashi, Kenta Matoba, Yasuhiro Ohata, Naoya Shimizu, Agena Suzuki, Satoe Fujii, Marie Sato, Koji Takano, Masayoshi Shichiri
Publikováno v:
Renal Replacement Therapy, Vol 8, Iss 1, Pp 1-8 (2022)
Abstract Background The number of dialysis patients with diabetes is currently increasing in Japan and a similar proportion worldwide. It was suggested that approximately 20% of these patients had hypoglycemia after dialysis session and most of these
Externí odkaz:
https://doaj.org/article/ee7ad02457fa4f01a35bc8bebfe3776d
Autor:
Tatsuhiko Wada, Makoto Hibino, Hiromi Aono, Shunsuke Kyoda, Yosuke Iwadate, Eri Shishido, Keisuke Ikeda, Nana Kinoshita, Yasuki Matsuda, Sakiko Otani, Ryo Kameda, Kenta Matoba, Miwa Nonaka, Mika Maeda, Yuji Kumagai, Junya Ako, Masayoshi Shichiri, Katsuhiko Naoki, Masato Katagiri, Masashi Takaso, Masatsugu Iwamura, Kazuhiko Katayama, Takeshi Miyatsuka, Yasushi Orihashi, Kunihiro Yamaoka, for the CORVETTE-01 Study Group
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundTo investigate whether ivermectin inhibits SARS-CoV-2 proliferation in patients with mild-to-moderate COVID-19 using time to a negative COVID-19 reverse transcription-polymerase chain reaction (RT-PCR) test.MethodsCORVETTE-01 was a double-b
Externí odkaz:
https://doaj.org/article/87f69fbbd4f54086bd8558e95afb013b
Autor:
Naoya Shimizu, Akinori Hayashi, Shiori Ito, Agena Suzuki, Rei Fujishima, Kenta Matoba, Tatsuhiko Wada, Koji Takano, Masato Katagiri, Masayoshi Shichiri
Publikováno v:
Endocrine Journal. 69:597-604
The clinical utility of intermittently scanned continuous glucose monitoring (isCGM) in patients with coronavirus disease 2019 (COVID-19) is unclear. Hence, we investigated the accuracy of isCGM in COVID-19 patients during dexamethasone therapy. We e
Autor:
Akinori Hayashi, Naoya Shimizu, Agena Suzuki, Rei Fujishima, Kenta Matoba, Ibuki Moriguchi, Naoyuki Kobayashi, Takeshi Miyatsuka
Publikováno v:
Journal of Diabetes and its Complications. 37:108470
Autor:
Ibuki Moriguchi, Agena Suzuki, Kenta Matoba, Koji Takano, Akari Momozono, Naoyuki Kobayashi, Masayoshi Shichiri, Akinori Hayashi, Naoya Shimizu, Akifumi Ogawa, Tsuguto Masaki
Publikováno v:
Diabetes Care. 44:1647-1656
OBJECTIVE There is a high risk of asymptomatic hypoglycemia associated with hemodialysis (HD) using glucose-free dialysate; therefore, the inclusion of glucose in the dialysate is believed to prevent intradialytic hypoglycemia. However, the exact gly
Autor:
Ibuki Moriguchi, Masayoshi Shichiri, Naoya Shimizu, Akinori Hayashi, Naoyuki Kobayashi, Kenta Matoba
Publikováno v:
Journal of diabetes and its complications. 34(11)
Introduction We evaluated the accuracy and clinical utility of flash glucose monitoring (FGM) in comparison with continuous glucose monitoring (CGM) and self-monitoring blood glucose (SMBG) in patients with type 2 diabetes (T2D) undergoing hemodialys